top of page

Whartons Jelly Injection Therapy
Whartons Jelly is a ground breaking non-operative treatment option that relieves pain by naturally promoting long lasting healing of musculoskeletal conditions. 

How do Wharton’s Jelly Allografts work?

Umbilical cord tissue  is shown to be structurally similar to articular cartilage and other soft tissues throughout the body. There are many components of Whartons Jelly (WJ) that are beneficial for transplantation. The most prominent of these components is the ECM (extracellular matrix), a collagen-based, cross-linked network that adds tensile strength and distributes load, making it an excellent  choice for patients with musculoskeletal injuries.


Wharton’s jelly (WJ) allografts consist of human umbilical cord tissue  that has been disassociated, suspended in saline, and cryopreserved. Their main function is to replace missing or damaged tissue  in the patient, applied directly to the defect, or injured area, in soft tissues. They are applied via syringe and are typically used in ligament, muscle, or cartilage tears.

How is Wharton’s jelly administered?

Wharton’s jelly is administered via syringe, directly to the injured site, or defect. The application is relatively painless and takes mere  minutes.


How many applications do I need?

This is determined by your physician depending on your specific case, but typically multiple applications are required to reach the desired clinical outcome.


Is Wharton’s jelly application safe?

Yes! There have  been no known graft vs. host interactions nor drug interactions with our product. As always, your physician will determine if this product is safe for you. To date, no adverse events have been reported contributable to Regenative Labs’ products in over 50,000 applications.

Regenerative Products Comparison


Which Conditions benefit most from Whartons Jelly?

Wharton’s  jelly allografts are connective tissue  supplements designed to replace missing or damaged tissue in the patient.  If missing or damaged tissue is identified after imaging, you may be a candidate for Wharton’s  jelly application.

How do I know if Wharton’s jelly is right for me?

If you are suffering from joint pain, you may have an underlying structural tissue  defect that is the root cause. Instead  of treating your symptoms (pain) with steroids or other conventional methods, Wharton’s  jelly addresses the root cause by fixing your "tissue issue".

Advantages of Whartons Jelly

This connective tissue contains  high amounts of extracellular  matrix components including collagen types I, III, and V, elastin, and fibronectin that provide a natural

scaffold to facilitate cellular adhesion1, 2. Wharton’s jelly primarily provides cushioning  and structural support to the umbilical cord but also contains  a natural source of long- chain hyaluronic acid as well as numerous cytokines  and growth  factors. Studies  have  described placental tissues  to be “immune privileged” as they rarely evoke  an immune response in the body, reducing the risk of adverse reaction.


What is a structural defect?

 A defect is defined  as missing or damaged tissue  in the body. Missing or damaged tissue  often compromises the stability and structural integrity of its surrounding area, providing for a wide array  of symptoms.

Supplementing a Defect

Regenative Labs Wharton’s jelly allografts are derived from the structural connective tissue found in the umbilical cord. This structural connective tissue provides cushioning and structural support to the vasculature in the umbilical cord. All Regenative Labs Wharton’s jelly allografts are processed to preserve the structural integrity and original relevant  characteristics of the connective tissue relating to its utility to supplement missing or damaged tissue in the recipient. If you may be dealing with a structural defect, ask your physician if you could benefit from connective tissue supplementation.

What should I do post-application?

This is up to your physician's discretion, however it is usually a good  idea to take it easy  for the first 24-48 hours, but beyond that, there  is typically little change in daily activities post-application. WJ  application takes only minutes & is non-allogeneic, non-

surgical, and minimally invasive. Patients walk in and walk back  out the same day.

Scientist in the Lab
Lab Worker preparing products


Our Whartons Jelly is developed by Regenative Labs in FL.

Regenative Lab’s mission is to facilitate predictable patient  outcomes by providing the highest quality human tissue  allografts available. With the goal of addressing the root cause, rather than masking the pain, Regenerative Labs birth tissue  allografts provide a non-addictive, minimally invasive option for patients.


Our Lab:  Regenative Labs products are manufactured in state-of-the-art ISO certified cleanrooms. All equipment is calibrated and validated to ensure valid and consistent results  are produced.



 •  Advanced Air Quality Systems

•  ISO Class 5 Biological Safety Cabinets

•  Ultra-Low -80C Freezer Systems

•  Advanced Quality Control Systems

Regenative Labs Wharton’s jelly allografts are regulated under  section  361 of the Public Health Service  Act (PHS) and 21 CFR Part 1271 and are intended for homologous use  only. Regenative Labs processes the Wharton’s jelly to preserve the structural integrity and original relevant characteristics of the tissue  as observed in the donor.

Regenative Labs’ products are ethically derived  and do not contain  any material obtained from an embryo or fetus. These  birth tissue  allografts are derived  from healthy, consenting mothers after full-term, live, planned,  Cesarean section  (C-section) deliveries.


Regenative Lab’s mission is to facilitate predictable patient outcomes by providing the highest  quality human tissue  allografts available. With the goal of addressing the root cause, rather than masking the pain, Regenative Labs birth tissue  allografts provide  a non-addictive, non-invasive option for patients.


Our first-class, state-of-the-art production facility is located  in Pensacola, Florida. We spare no expense when  it comes to the technology that we all insist is necessary to produce the quality regenerative products we expect for our partners.


REGENATIVE  LABS’  HIGH-QUALITY  PROCESSING Regenative Labs birth tissue  allografts are derived  from healthy, consenting mothers after full-term, live, planned,  Cesarean section  (C-section) deliveries.. Donors are healthy  women who are thoroughly  screened for risk factors  and clinical evidence of relevant  communicable diseases. A careful medical and social history is collected  in advance to ensure the donor  meets all eligibility requirements.


These  non-embryonic tissues  undergo extensive medical, social and blood testing prior to processing. Only tissue  cleared after this stringent screening regimen are processed and re-tested in accordance with standards established by the American Association of Tissue Banks (AATB) and FDA requirements. Every precaution is taken  to eliminate potential risk of infectious diseases through  comprehensive testing in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR Part 493 and the FDA. Regenative Labs verifies each  step  of the manufacturing process to ensure the most  stringent safety standards are met  and maintained,  from start  to finish.


bottom of page